Seneca Biopharm Inc (SNCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SNCA | AMGN | BMY | GILD | ILMN |
| Company | Seneca Biopharm Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 9.9000 | 265.64 | 47.93 | 67.01 | 116.25 |
| High | 10.0278 | 265.92 | 48.41 | 67.02 | 119.18 |
| Low | 9.7200 | 262.58 | 47.62 | 65.90 | 115.73 |
| Last | 9.9600 | 262.75 | 48.30 | 66.16 | 116.69 |
| Change | -0.1200 | -1.32 | +0.46 | -0.77 | -1.60 |
| % Change | -1.19% | -0.50% | +0.96% | -1.15% | -1.35% |
| Volume | 194,116 | 2,082,700 | 10,917,500 | 6,442,200 | 1,810,300 |
| 20-Day Average Volume | 1,882,520 | 2,201,900 | 11,419,555 | 6,214,910 | 1,527,960 |
| Previous Close | 10.0800 | 264.07 | 47.84 | 66.93 | 118.29 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6135 | 272.96 | 50.99 | 70.21 | 129.39 |
| 20-Day Raw Stochastic | 58.18% | 0.65% | 9.99% | 3.10% | 3.37% |
| 20-Day Relative Strength | 52.73% | 36.64% | 37.48% | 27.91% | 35.49% |
| Weighted Alpha | +97.27 | +4.25 | -30.16 | -25.27 | -46.00 |
| Today's Opinion | 96% Buy | 56% Sell | 72% Sell | 100% Sell | 72% Sell |
| Previous Opinion | 96% Buy | 56% Sell | 56% Sell | 100% Sell | 72% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 24% Sell | 88% Sell | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.16% since 04/20/21 | -2.69% since 04/11/24 | -1.67% since 04/11/24 | -3.63% since 04/11/24 | -10.72% since 04/11/24 |
| Low | 1.4501 on 04/21/21 | 262.58 on 04/18/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 1.8800 on 04/26/21 | 270.93 on 04/15/24 | 49.10 on 04/15/24 | 68.62 on 04/12/24 | 134.85 on 04/12/24 |
| 1-Month | |||||
| %Chg | +7.10% since 03/26/21 | -3.01% since 03/18/24 | -6.38% since 03/18/24 | -9.69% since 03/18/24 | -10.34% since 03/18/24 |
| Low | 1.3400 on 04/16/21 | 262.58 on 04/18/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 1.8900 on 04/06/21 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 74.28 on 03/21/24 | 144.19 on 03/21/24 |
| 3-Month | |||||
| %Chg | +22.96% since 01/27/21 | -13.71% since 01/18/24 | -3.57% since 01/18/24 | -23.43% since 01/18/24 | -13.07% since 01/18/24 |
| Low | 1.0301 on 03/04/21 | 262.58 on 04/18/24 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 2.6700 on 03/22/21 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +167.74% since 10/27/20 | -7.35% since 10/18/23 | -15.04% since 10/18/23 | -16.96% since 10/18/23 | -6.24% since 10/18/23 |
| Low | 0.5394 on 11/05/20 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 89.00 on 11/10/23 |
| High | 2.6700 on 03/22/21 | 329.72 on 02/05/24 | 57.09 on 10/20/23 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 28,711 | 141,520,144 | 96,960,152 | 83,333,008 | 18,838,276 |
| Shares Outstanding, K | 17,296 | 535,919 | 2,026,759 | 1,245,077 | 159,255 |
| Annual Sales | 10,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -16,270,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 2,500 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -4,418,839 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | -176,000,000 |
| 60-Month Beta | 1.88 | 0.58 | 0.39 | 0.19 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/21/21 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.24 | 6.43 | 10.02 | 135.28 |